In order to confirm that cellular GSNO resistance is due to fact that GSNO may be a substrate for both P-gp and BCRP, we used verapamil and Ko143, known inhibitors for P-gp [35,36] and BCRP [37,38], respectively to examine GSNO cytotoxicity in these tumor cell lines. This evidence concerns the gene PGP and neoplasm.